SEC Form 4 · accession 0001179110-18-004814
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tom Maniatis
Director
Period of report
Mar 21, 2018
Accepted (ET)
Mar 23, 2018 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2018 | M | 18,750 | $5.08 | A | 135,481 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $5.08 | Mar 21, 2018 | M | 18,750 | D | — | Mar 27, 2018 | Common Stock | 18,750 | 0 | D |
Explanation of responses
- F1The options of registrant's common stock vested as to one third of the shares annually beginning on the first anniversary of the grant.